183 related articles for article (PubMed ID: 18797200)
21. Central venous catheter-associated bloodstream infections.
Newman N; Issa A; Greenberg D; Kapelushnik J; Cohen Z; Leibovitz E
Pediatr Blood Cancer; 2012 Aug; 59(2):410-4. PubMed ID: 22535579
[TBL] [Abstract][Full Text] [Related]
22. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
23. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
24. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study.
Elishoov H; Or R; Strauss N; Engelhard D
Medicine (Baltimore); 1998 Mar; 77(2):83-101. PubMed ID: 9556701
[TBL] [Abstract][Full Text] [Related]
25. Removal of percutaneously inserted central venous catheters in neonates is associated with the occurrence of sepsis.
van den Hoogen A; Brouwer MJ; Gerards LJ; Fleer A; Krediet TG
Acta Paediatr; 2008 Sep; 97(9):1250-2. PubMed ID: 18477060
[TBL] [Abstract][Full Text] [Related]
26. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer.
Flynn PM; Willis B; Gaur AH; Shenep JL
J Clin Oncol; 2003 Sep; 21(18):3520-5. PubMed ID: 12972529
[TBL] [Abstract][Full Text] [Related]
27. A reliable and safe method of collecting blood samples from implantable central venous catheters for determination of plasma gentamicin concentrations.
Chen J; Boodhan S; Nanji M; Chang A; Sekharan S; Lavoratore S; Brandão LR; Skolnik JM; Dupuis LL
Pharmacotherapy; 2011 Aug; 31(8):776-84. PubMed ID: 21923604
[TBL] [Abstract][Full Text] [Related]
28. [Infective complications of the use of permanent central venous catheters in oncology].
Barriga F; Varas M; Capdeville MV; Sapunar F; Lira P; Grebe G
Rev Med Chil; 1992 Jul; 120(7):783-8. PubMed ID: 1341820
[TBL] [Abstract][Full Text] [Related]
29. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
[TBL] [Abstract][Full Text] [Related]
30. An unusual presentation of sepsis caused by coagulase-negative staphylococci.
Nieboer P; Gietema JA; de Vries-Hospers HG; van der Graaf WT
Neth J Med; 1999 Sep; 55(3):155-9. PubMed ID: 10509075
[TBL] [Abstract][Full Text] [Related]
31. Management of septic complications associated with Silastic catheters in childhood malignancy.
Hartman GE; Shochat SJ
Pediatr Infect Dis J; 1987 Nov; 6(11):1042-7. PubMed ID: 3696842
[TBL] [Abstract][Full Text] [Related]
32. Incidence of catheter-related infections within 30 days from insertion of Hickman-Broviac catheters.
Castagnola E; Molinari AC; Giacchino M; Chiapello N; Moroni C; Caviglia I; Fratino G; Haupt R
Pediatr Blood Cancer; 2007 Jan; 48(1):35-8. PubMed ID: 16358302
[TBL] [Abstract][Full Text] [Related]
33. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
[TBL] [Abstract][Full Text] [Related]
34. [Sepsis in children with malignant neoplasia, equipped with a Broviac-type venous catheter].
Garaventa A; Castagnola E; Dallorso S; Dini G; Trucco D; Vianello O; Carrega G; Cuneo P; Buffa P; Magillo P
Pediatr Med Chir; 1995; 17(2):147-50. PubMed ID: 7610079
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2.
Chemaly RF; Sharma PS; Youssef S; Gerber D; Hwu P; Hanmod SS; Jiang Y; Hachem RY; Raad II
Int J Infect Dis; 2010 Jul; 14(7):e548-52. PubMed ID: 20005762
[TBL] [Abstract][Full Text] [Related]
36. [Bacteremia in children with tumors or malignant diseases 1991-2000].
Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
[TBL] [Abstract][Full Text] [Related]
37. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.
Laoprasopwattana K; Pruekprasert P; Laosombat V; Wongchanchailert M
Pediatr Hematol Oncol; 2007 Dec; 24(8):595-606. PubMed ID: 18092250
[TBL] [Abstract][Full Text] [Related]
39. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of ticarcillin-clavulanate and gentamicin as empiric treatment for febrile neutropenic pediatric patients with cancer.
Yu LC; Shaneyfelt T; Warrier R; Ode D
Pediatr Hematol Oncol; 1994; 11(2):181-7. PubMed ID: 8204443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
